Chula, Thai Red Cross Launch Herbal Artificial Saliva Product Targeting Aging Population
Event summary
- Chulalongkorn University, Thai Red Cross Society, and Specialty Innovation Co., Ltd. have launched 'SALYWA,' an artificial saliva product utilizing Thai herbal extracts.
- The product is protected by a petty patent jointly held by Chulalongkorn University and the Thai Red Cross Society.
- SALYWA is priced at 300 THB for a 50ml gel and 275 THB for a 30ml spray, and will be distributed through a charitable fund to underprivileged patients.
- Thailand's rapidly aging population (over 20% aged 60+) creates a significant market for products addressing xerostomia (dry mouth).
The big picture
Thailand's demographic shift towards an aging population is creating a growing demand for geriatric healthcare solutions. Chulalongkorn University's collaboration with the Thai Red Cross Society leverages academic research to address a specific unmet need, demonstrating a trend toward public-private partnerships in healthcare innovation. The charitable distribution model, while socially commendable, may also introduce complexities in pricing and profitability.
What we're watching
- Market Adoption
- The success of SALYWA will depend on its ability to penetrate the Thai market, particularly among elderly individuals and cancer patients, and compete with existing solutions.
- Regulatory Landscape
- Future regulatory changes regarding herbal remedies or artificial saliva products could impact SALYWA’s classification and distribution channels.
- Scalability
- The ability of Specialty Innovation Co., Ltd. to scale production and distribution while maintaining product quality and charitable distribution commitments will be crucial for long-term sustainability.
Related topics